By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent said today it has registered its 80,000 square-foot manufacturing facility in Cedar Creek, Texas, with the US Food and Drug Administration as a medical device establishment.

The registration is required for manufacturing diagnostic products, which the Santa Clara, Calif.-based firm said it intends to develop.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Gene drives might run into biological resistance, the Economist reports.

Forensic experts exhumed painter Salvador Dalí's body to collect DNA for a paternity test, CBS News reports.

Yale Environment 360 writes that synthetic and conservation biologists aren't always on the same wavelength, but they are trying to reach an understanding.

In Science this week: full CRISPR locus integration complex structure, and more.